Cookies

Like most websites The Translational Scientist uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.

Search

Reset Filter
You have a filtered search result

26 search results for ‘*’


Tools & Techniques Clinical trials

Data Damage

| Angus Stewart

The war in Ukraine has massively impacted clinical trials. We spoke to one man tracking the disruption.


Tools & Techniques Analytical science

Using Mass Spec to Rewrite Textbooks

| Lauren Robertson

We sit down with Albert J.R. Heck, Professor at the Science Faculty, Utrecht University, and Scientific Director of the Netherlands Proteomics Centre

Research Field Drug discovery

Prodrugs Assemble

Work by an international team in Japan has found a new and effective way to attack cancer inside the body.

Tools & Techniques Drug discovery

Anthrax: an Unlikely Ally

| Angus Stewart

Boston bioscientists have found an unlikely ally in anthrax toxins, which could form the basis for a new kind of painkiller.

Research Field Drug discovery

Nurse Sharks and VNARs

| Angus Stewart

How work on sharks could provide a highly effective weapon against new COVID variants

Outside the Lab Professional development

The Analytical Neuroscientist

We sit down with "The Analytical Neuroscientist," Jonathan Sweedler

Research Field Cancer

Heidelberg Heroes

What can the Professor X of Heidelberg tell us about a new way of tackling cancer?

Research Field Drug discovery

Meet the Microbiome Matchmaker

A 2000-participant study in Europe has examined how drugs – and combinations of drugs – can affect the microbiota in our gut.

Research Field Drug discovery

The Tale of Two TULIPs

| Angus Stewart

A drug development journey with origins in the 1950s has finally reached its successful conclusion: a new treatment for lupus

Research Field Drug discovery

Unleashing Cellular Potential

| James Strachan

Mogrify's Karin Schmitt explains how epigenetic switches are support the conversion and maintenance of any clinically valuable cell types

Register to The Translational Scientist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts

Register